Transformative heart procedure circulates to Marian Regional
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Community Memorial rebrands to signal a new era
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Sientra announces reverse stock split to boost shares
Sientra, a medical aesthetics company focused on breast augmentation, announced on Jan. 20 that its board of directors approved a 1-for-10 reverse stock split of the company’s issued and outstanding common stock. The reverse stock split was effective as of 1 p.m. on Jan. 19 while the company’s common stock began trading on the Nasdaq Read More →
Sansum aims to set new standard of care for diabetes patients in 2023
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
CRELY aims to detect problems early
Catching issues early is sometimes the best form of medicine there is. With enough time, power and resources, catching something early is the difference between life and death. For this medical-device startup out of Oxnard, catching something early is literally in its name. CRELY, a shorthand for credible, reliable, and early, was founded in 2018, Read More →
Inogen sees slight stock climb behind regulatory wins
Goleta-based Inogen saw its stock climb about 3% after the company achieved regulatory milestones in the European Union and the United States to support its products and shared its preliminary fourth quarter and full-year revenue results on Jan. 10. Inogen, a maker of portable oxygen containers, received European Medical Device Regulation certification from the British Read More →
Arcutis approves equity grants
Westlake Village-based Arcutis Biotherapeutics announced the grant of an aggregate of 17,050 restricted stock units of Arcutis’ common stock as well as options to purchase an aggregate of 33,550 shares of Arcutis’ common stock to five newly hired employees. The stock options have a ten-year term and an exercise price of $14.77 per share, equal to Read More →
